Strokes can and do happen to people who take blood pressure medication every day. Medication substantially reduces the risk, but it never eliminates it completely. One large study found that even among people whose treatment brought systolic blood pressure below 120 mmHg, those who needed three or more drug classes to get there still carried a stroke risk comparable to someone with untreated stage 1 hypertension. The reasons for this residual risk are varied, ranging from blood pressure swings the medication cannot fully tame, to stroke causes that have nothing to do with blood pressure at all.
Residual Risk Even With Good Blood Pressure Control
If your blood pressure readings look fine at the doctor’s office, you might assume your stroke risk has returned to normal. The data suggest otherwise. A study of participants in the Reasons for Geographic and Racial Differences in Stroke cohort showed that roughly half of those with hypertension achieved controlled readings below 140 mmHg with treatment. Yet within each blood pressure range, stroke risk climbed with every additional class of blood pressure drug required to maintain that control. A person whose blood pressure sat below 120 mmHg on three or more medications had a slightly higher stroke risk than someone with untreated stage 1 hypertension. The implication is that the body’s underlying cardiovascular condition matters independently of the number you see on the cuff.
1PubMed Central. Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertensionPeople with treatment-resistant hypertension face an even steeper challenge. When blood pressure stays elevated despite taking three or more medications at adequate doses, or requires four or more drugs to control, the condition is termed apparent treatment-resistant hypertension. Registry data show these patients have a meaningfully higher lifetime risk of both ischemic and hemorrhagic stroke, along with elevated risks of heart failure, kidney failure, and cardiovascular death.
2European Journal of Preventive Cardiology. Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registryBlood Pressure Swings Your Medication May Not Catch
Blood pressure is not a static number. It fluctuates throughout the day, drops during sleep, and can spike sharply in the early morning hours. A once- or twice-daily pill smooths the average, but it does not erase every swing. That matters because these fluctuations independently predict stroke risk.
The morning surge in blood pressure, the sharp rise that occurs as you wake up, has been studied extensively in older adults with hypertension. In a prospective study of over 500 elderly hypertensive patients, those in the top 10% of morning surge magnitude (a jump of 55 mmHg or more) had a stroke incidence of about 19% over the follow-up period, compared with roughly 7% in everyone else. Even after adjusting for 24-hour blood pressure levels and nighttime dipping patterns, the morning surge remained an independent predictor of stroke.
3PubMed. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective studyA broader pattern also plays a role. Fluctuations in blood pressure measured across separate clinic visits, known as visit-to-visit variability, are themselves a strong predictor of cerebrovascular events. Research shows this variability predicts both first and recurrent strokes and is associated with worse functional outcomes, independent of what your average blood pressure reading turns out to be.
4PubMed Central. Blood pressure variability and stroke: A risk marker of outcome and target for interventionSo if your blood pressure is 125/78 at one visit and 148/92 at the next, the instability itself is part of the problem, not just whichever reading was higher. Standard medication regimens do not always address this kind of variability, which is one reason your doctor may care about consistency of readings over time rather than just individual numbers.
When Blood Pressure Drops Too Low
It seems intuitive that lower blood pressure should always mean lower stroke risk. In practice, the relationship is more complicated, particularly for people already on medication. Several lines of evidence point to what researchers call a J-curve: as blood pressure drops below a certain threshold, the risk of bad outcomes starts climbing again rather than continuing to fall.
In treated hypertensive patients, one study found a statistically significant increase in stroke risk in the lowest category of diastolic blood pressure compared with a middle reference group. The authors concluded that “the lower the better” is probably not the right strategy for elderly patients on treatment.
5PubMed. J-shaped relation between blood pressure and stroke in treated hypertensivesAnalyses of diastolic pressure specifically have reinforced this. A study from a tertiary hypertension clinic found a U-shaped relationship between diastolic blood pressure and stroke admissions: risk was elevated at both high and low ends. In younger patients, the pattern was particularly clear.
6PubMed Central. Diastolic Blood Pressure J-Curve Phenomenon in a Tertiary-Care Hypertension ClinicThe mechanism is debated. Some researchers believe that very low diastolic pressure reduces blood flow to the brain and heart during the part of the cardiac cycle when the heart relaxes, starving tissue of oxygen. Others argue it may simply be a marker of poor underlying health rather than a direct cause. Both camps agree that the J-curve is real enough to warrant caution.
7American Heart Journal Plus: Cardiology Research and Practice. The diastolic blood pressure J-curve revisited: An updateThe practical danger shows up most starkly in acute situations. A case series documented six patients who suffered new or worsened ischemic neurologic deficits after receiving antihypertensive medications that lowered their mean arterial pressure by about 25%, without ever producing frank hypotension. In the setting of an acute stroke or transient ischemic attack, even moderate blood pressure reduction can push a vulnerable brain over the edge.
8PubMed. Stroke precipitated by moderate blood pressure reductionStroke Risk Factors That Blood Pressure Medication Cannot Fix
Blood pressure is the single largest modifiable risk factor for stroke, but it is far from the only one. Several conditions raise stroke risk through pathways that have little to do with the numbers on a blood pressure cuff, and no antihypertensive drug can address them.
Atrial fibrillation, the most common sustained heart rhythm disorder, is a major independent stroke risk factor. Even when patients with atrial fibrillation are anticoagulated (treated with blood thinners), the residual annual risk of stroke or systemic embolism ranges from about 1% to nearly 3% per year depending on their overall risk profile, and real-world studies report rates at the higher end of that range.
9Arrhythmia & Electrophysiology Review. Residual Stroke Risk in Atrial FibrillationDiabetes is another culprit. People with diabetes have a higher risk of lacunar strokes, the small, deep brain infarcts caused by disease in the tiny arteries deep inside the brain. A genetic analysis estimated that hypertension raises lacunar stroke risk by about 42% and type 2 diabetes adds another 9%, each independently of the other.
10PubMed. The effect of hypertension, obesity, and type 2 diabetes on lacunar stroke: A network Mendelian randomization studyAmong patients who had already experienced a lacunar stroke, those with diabetes were significantly more likely to have infarcts in the brainstem or cerebellum and to have narrowing of the arteries inside the skull compared with non-diabetic patients.
11PubMed Central. Lacunar strokes in patients with diabetes: Risk factors, infarct location, and prognosis: The SPS3 StudyArterial stiffness adds yet another layer. As arteries lose their elasticity, pulse pressure (the gap between systolic and diastolic readings) widens. That pounding pulse drives plaque formation and remodeling of artery walls, eventually setting the stage for plaque rupture and stroke.
12Stroke and Vascular Neurology. Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for strokeNone of these conditions are solved by blood pressure pills alone. Someone whose blood pressure is perfectly controlled but who also has untreated atrial fibrillation, unmanaged diabetes, or advanced arterial stiffness still faces real stroke risk.
Adherence and Medications That Undermine Your Treatment
The most effective blood pressure drug in the world cannot work if you do not take it. Adherence to antihypertensive medications follows a dose-response relationship with stroke risk: the more consistently you take your pills, the lower your risk. A meta-analysis found that higher adherence was associated with a roughly 26% lower risk of ischemic stroke and a 45% lower risk of hemorrhagic stroke compared with poor adherence.
13PubMed Central. Adherence to Antihypertensive Medications and Stroke Risk: A Dose-Response Meta-AnalysisStopping medication entirely, even in situations where a doctor is considering deprescribing for an elderly patient, comes with measurable consequences. In a Cochrane review of trials where older adults discontinued antihypertensives, systolic blood pressure climbed by about 10 mmHg on average in the discontinuation group. Somewhere between 10% and 33% of those who stopped needed to restart therapy due to rising pressure or other clinical red flags.
14Cochrane Library. Withdrawal of antihypertensive drugs in older peopleThe stroke signal in those trials was not statistically clear, but the studies were small and short. The point estimate still suggested higher odds of stroke in the group that stopped, and blood pressure itself clearly rebounded.
15Cochrane Database of Systematic Reviews. Withdrawal of antihypertensive drugs in older peopleOver-the-counter painkillers are a surprisingly common saboteur. Nonsteroidal anti-inflammatory drugs like ibuprofen, naproxen, and indomethacin can raise diastolic blood pressure by 5 to 6 mmHg. That sounds modest, but sustained over time, an increase of that size has been linked to a roughly 67% increase in total stroke risk. Some NSAIDs are worse offenders than others, and they tend to interfere more with beta-blockers than with other drug classes.
16PubMed. NSAIDs and increased blood pressure. What is the clinical significance?If you regularly take ibuprofen or naproxen for joint pain or headaches while also being treated for high blood pressure, your medication may be working against a constant headwind. Mention it to your prescriber; there may be a safer alternative for pain management.
Blood Pressure Targets and Which Drugs Work Best for Stroke Prevention
For people who have already had a stroke, the question of how aggressively to lower blood pressure has a clearer answer than it used to. A systematic review of randomized trials comparing intensive control (systolic below 130) with standard control (systolic below 140) found that intensive control reduced recurrent stroke by about 21% and major cardiovascular events by about 14%. The absolute benefit worked out to roughly 14 fewer recurrent strokes per 1,000 people treated. Side effects like dizziness and fainting were more common in the intensive group, but the absolute increase was small, about 4 extra cases per 1,000 people.
17Hypertension Research. Optimal blood pressure target for patients with prior stroke: A systematic review and meta-analysisThat benefit was not distributed evenly across stroke types. Intensive blood pressure lowering was dramatically more effective at preventing hemorrhagic stroke, the kind caused by bleeding in the brain, than ischemic stroke, the kind caused by a blocked artery. In one post hoc analysis, intensive treatment eliminated hemorrhagic recurrences entirely (0% vs. 0.39% per year) while making virtually no difference in ischemic recurrence rates.
18Hypertension Research. Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysisAs for which medications, current international guidelines from major cardiology societies agree on a core group for secondary stroke prevention: thiazide diuretics, ACE inhibitors, and angiotensin receptor blockers are the go-to choices for long-term blood pressure management after a stroke. Calcium channel blockers are effective at lowering blood pressure and are commonly used, though the evidence specifically tying them to stroke recurrence prevention is thinner. Beta-blockers are less effective for stroke prevention than the other major drug classes and are generally reserved for patients who need them for other reasons, such as heart failure or a rapid heart rate.
19Hypertension Research. Blood pressure management in stroke: comparative review of the 2025 AHA/ACC/AANP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM, 2024 ESC, 2023 ESH, and 2025 JSH guidelinesWhen Your Office Blood Pressure Looks Normal but Isn’t
There is a scenario where blood pressure medication appears to be working perfectly and your office readings are consistently fine, yet your blood pressure is actually elevated most of the day. This is called masked hypertension: normal readings at the clinic, elevated readings outside of it. It is the mirror image of white-coat hypertension, where readings jump only in the doctor’s office.
Masked hypertension carries real consequences. In the Ohasama study, a 10-year follow-up of community-dwelling residents, people with masked hypertension had more than double the cardiovascular risk of those with truly normal blood pressure. The hazard was essentially the same as having sustained hypertension confirmed both in the office and at home. These findings held for stroke specifically and were consistent across sex and among those already on blood pressure medication.
20PubMed. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama studyThe problem, of course, is that masked hypertension is invisible unless you look for it with home monitoring or a 24-hour ambulatory blood pressure device. Studies using ambulatory monitoring to cross-classify patients have confirmed that white-coat hypertension is relatively benign while masked hypertension carries a hazard nearly as high as persistently elevated blood pressure in all settings.
21PubMed Central. Ambulatory Blood Pressure Monitoring to Diagnose and Manage HypertensionIf you are on blood pressure medication and your office readings consistently look good, but you have risk factors that seem out of proportion to those numbers, or if you have experienced a stroke despite apparently controlled hypertension, asking your doctor about ambulatory monitoring is reasonable. It may reveal a pattern that clinic visits alone cannot capture.
The Hemorrhagic and Ischemic Divide
People tend to think of stroke as one disease, but the two major types respond quite differently to blood pressure management. Hemorrhagic stroke, caused by a burst blood vessel in the brain, is tightly linked to high blood pressure and responds strongly to treatment. Ischemic stroke, caused by a clot blocking blood flow, is influenced by blood pressure but also by cholesterol, heart rhythm, blood clotting, and the condition of artery walls.
This distinction explains a recurring finding in the research: intensive blood pressure control reliably reduces hemorrhagic strokes but has a more modest and sometimes nonsignificant effect on ischemic strokes. A meta-analysis of trials in patients with prior stroke reported a 67% reduction in recurrent hemorrhagic stroke with intensive control but only a 13% reduction in ischemic stroke that did not reach statistical significance.
17Hypertension Research. Optimal blood pressure target for patients with prior stroke: A systematic review and meta-analysisThe adherence data tell a similar story from a different angle. When people consistently took their blood pressure pills, the protective effect was larger for hemorrhagic stroke (about a 45% risk reduction) than for ischemic stroke (about a 26% reduction).
13PubMed Central. Adherence to Antihypertensive Medications and Stroke Risk: A Dose-Response Meta-AnalysisFor someone whose primary concern is hemorrhagic stroke, whether because of a family history, prior bleed, or a condition like cerebral amyloid angiopathy, the case for aggressive blood pressure management is especially strong. For ischemic stroke prevention, blood pressure control still matters a great deal, but the protection ceiling is lower because so many other factors feed into clot-related strokes. Addressing cholesterol, atrial fibrillation, and blood sugar alongside blood pressure is what closes the remaining gap.